Global Brain Imaging Modalities Market - 1-3 USERS:2022

Global Brain Imaging Modalities Market - 1-3 USERS:2022

Global Brain Imaging Modalities Market - A Global and Regional Analysis: Focus on Product Type, Patient Age, End User, and Regional Analysis - Analysis and Forecast, 2022-2031

€4,830.00

Details

Market Report Coverage :
Start Year : 2022 - Forecast Year : 2031 - Start Value : $12,963.1 Million in 2022 - Forecast Value : $20,209.2 Million by 2031 - CAGR % : 0.05%
Description :
Market Report Coverage - Brain Imaging ModalitiesMarket Segmentation• Product - CT Devices, MRI Devices, PET Devices, PET-CT Devices and PET-MRI Devices• Patient Type - Adults and Pediatrics and Infants• End User - Hospitals and Clinics, Diagnostic Imaging Centers, and Ambulatory Surgical CentersRegional Segmentation• North America - U.S. and Canada• Europe - Germany, U.K., France, Italy, Spain, and Rest-of-Europe• Asia-Pacific - Japan, China, South Korea, India, Australia and New Zealand, and Rest-of-Asia-Pacific• Rest-of-the-World - Latin America, and Middle East and AfricaMarket Growth Drivers• Rising Prevalence of Neurological Disorders and Traumatic Brain Injuries (TBI)• Technological Advancements in the Brain Imaging Modalities and Systems• Growing Popularity of Molecular Imaging in Brain ImagingMarket Challenges• Hospital Budget Cuts and High Upfront Cost• Declining Helium AvailabilityMarket Opportunities• Integration of Imaging Systems and Software with Novel BiomarkersKey Companies ProfiledAspect Imaging, Canon, Inc., Esaote SpA, Fujifilm Holdings Corporation, General Electric Company, Hyperfine Inc., Koninklijke Philips N.V., Mediso Medical Imaging Systems, MinFound Medical Systems Co., Ltd., Samsung Electronics Co., Ltd., Shenzhen Anke High-Tech Co.,Ltd., Shimadzu Corporation, Siemens Healthineers AG, United Imaging Healthcare Co., Ltd., VUNO Co., Ltd.How This Report Can Add ValueAssuming that the reader is a manufacturer of brain imaging modalities, the report will assist them in the following ways:• Understand their position compared to other key players in the market• Stay updated with novel technology integration, features, and the latest developments in the market• Understand the impact of COVID-19 on brain imaging and the entry barriers for new companies• Gain insights into end-user perception concerning the brain imaging modalities market• Identify some key players in the market and understand their valuable contributionKey Questions Answered in the Report• How has COVID-19 impacted the growth of the global brain imaging modalities market?• What are the key regulations governing the brain imaging modalities market in key regions?• What technological developments are projected to have the maximum influence on the global brain imaging modalities market?• Who are the leading players holding significant dominance in the global brain imaging modalities market?• What are some of the growth opportunities which market players can capitalize on?• What are the drivers and restraints for the global brain imaging modalities market?• Which region has the highest growth rate in the brain imaging modalities market?• Which are the fastest growing countries in terms of the global brain imaging modalities market?• What are the key strategies being adopted by market players in the global brain imaging modalities market?• Which are the emerging companies in the global brain imaging modalities market?Global Brain Imaging Modalities Market Industry OverviewThe global brain imaging modalities market is projected to witness significant growth during the forecast period 2022-2031. The high prevalence and growing incidences of brain diseases and neurogenerative disorders and the technological advancements in brain imaging modalities and systems are the key propellers for the growth of the market. Five key modalities of brain imaging modalities include computed tomography (CT) devices, magnetic resonance imaging (MRI) devices, positron emission tomography (PET) devices, PET-CT devices, and PET MRI devices. The field of cognitive neuroscience has emerged and developed rapidly over the last 20 years. To address the neural underpinnings of human cognition, this new field combines two traditionally separate disciplines, cognitive psychology and neurology.The market for brain imaging modalities devices is rapidly growing, with an increasing number of modalities used in the imaging of various brain diseases and neurogenerative disorders (NDs). The high prevalence and growing incidences of neurological disorders (NDs) are one of the major factors augmenting the growth of the global brain imaging modalities market. Neurological diseases and mental disorders have emerged as serious public health concerns and substantial challenges to healthcare systems around the world. Genetic disorders, congenital anomalies or disorders, infections, lifestyle, or environmental health problems such as malnutrition, brain injury, spinal cord injury, or nerve injury are some of the causes of neurological problems.The global brain imaging modalities market report highlights that the market was valued at $12,334.2 million in 2021 and is expected to reach $20,209.2 million by the end of 2031. The market is expected to grow at a CAGR of 5.06% during the forecast period 2022-2031.Global Brain Imaging Modalities Market DriversPersonalized and tailored treatment approaches based on monitoring and imaging findings and respecting pre-injury comorbidities and their therapies are warranted due to traumatic brain injury is a syndrome encompassing a variety of different affections to the brain, and since age-related comorbidities and treatments may also have a significant impact. More importantly, as the prevalence and incidence of neurological illnesses continue to rise, so will technological adoption. As a result, the growth of disease diagnosis and, as a result, the global market for brain imaging modalities will accelerate.Governments invest a significant amount of money in healthcare insurance so that the overall healthcare costs can be reduced, and the quality of life and affordability of the treatment can be enhanced.Global Brain Imaging Modalities Market RestraintsThe factors restraining the growth of the global brain imaging devices market include the risks associated with radiation exposure and delay in regulatory approvals. Delay in regulatory approval for the products due to the stringent government regulations concerning the use of AI-enabled software in medical imaging hinders the market's growth. Moreover, another factor restraining the growth of the global brain imaging devices market is the high cost associated with medical imaging.Global Brain Imaging Modalities Market OpportunitiesHigh growth opportunities in emerging economies and the emergence of local companies in Asia-Pacific and the Middle East and Africa hold immense potential for the global brain imaging modalities market growth. In an era of machine learning and artificial intelligence, extracting quantitative biomarkers from medical images to aid illness detection, characterization, monitoring, and therapy response assessment is becoming increasingly desirable.Impact of COVID-19 on the Global Brain Imaging Modalities MarketThe COVID-19 pandemic had a debilitating impact on the global healthcare ecosystem. Hospitals and clinics faced several challenges such as lack of resources, high patient influx, and risk of infection among care providers. The market is projected to witness considerable growth during the forecast period 2021-2030. The increasing innovations and product designs in the global market and the growing use in emerging economies are the driving factors for the growth of the market.Market SegmentationGlobal Brain Imaging Modalities Market (by Product Type)The global brain imaging modalities market, based on product type, has been segmented into CT devices, MRI devices, PET devices, PET-CT devices, and PET-MRI devices.Global Brain Imaging Modalities Market (by Patient Type)The global brain imaging modalities market, based on patient type, has been segmented into adults, and pediatrics and infants.Global Brain Imaging Modalities Market (by End User)The global brain imaging modalities market, based on end user, has been segmented into hospitals and clinics, diagnostic imaging centers, and ambulatory surgery centers surgical centers.Hospitals and clinics are the major end users for the global brain imaging modalities market. The high volume of the end user makes them the primary diagnosis site for brain diseases and neurodegenerative disorders (NDs) in emerging economies. Furthermore, the adoption of brain imaging modalities in ASCs has been increased due to several factors such as personalized care to the patients and reduced recovery time.Global Brain Imaging Modalities Market (by Region)The different regions covered under the global brain imaging modalities market include North America, Europe, Asia-Pacific and Rest-of-the-World.North America is expected to be the most lucrative region for the global brain imaging modalities market due to advanced healthcare infrastructure and a high focus on research and development activities. The Asia-Pacific brain imaging modalities market is one of the lucrative markets with immense potential for expansion by key players of the global brain imaging modalities market. The Asia-Pacific brain imaging modalities market is expected to grow at the fastest rate during the forecast period. This can be attributed to the massive geriatric population base, which is driving the increase in the volume of brain imaging modalities.Key Market Players and Competition SynopsisSome key players operating in the market include Aspect Imaging, Canon, Inc., Esaote SpA, Fujifilm Holdings Corporation, General Electric Company, Hyperfine Inc., Koninklijke Philips N.V., Mediso Medical Imaging Systems, MinFound Medical Systems Co., Ltd., Samsung Electronics Co., Ltd., Shenzhen Anke High-Tech Co.,Ltd., Shimadzu Corporation, Siemens Healthineers AG, United Imaging Healthcare Co., Ltd., and VUNO Co., Ltd.Some strategies covered in this segment are funding activities, mergers and acquisitions (M&As), partnerships, alliances, business expansion, regulatory and legal activities, and new offerings.
Countries Covered :
North America U.S. CanadaEurope Germany Italy France U.K. Spain Rest-of-EuropeAsia-Pacific China India Japan South Korea Australia and New Zealand Rest-of-Asia-PacificRest-of-the-World Latin America Middle East and Africa
Keywords :
Brain Imaging Modalities Market, Brain Imaging Modalities Industry, Brain Imaging Modalities Report, Brain Imaging Modalities Market Forecasts, Brain Imaging Modalities Market Trends, Brain Imaging Modalities Market Companies, Brain Imaging Modalities Market Analysis, Brain Imaging Modalities Industry Analysis, What is Brain Imaging Modalities, Brain Imaging Modalities Definition, Brain Imaging Modalities Market Competitive Landscape, Brain Imaging Modalities Market Drivers, Brain Imaging Modalities Market Segments, Brain Imaging Modalities Market Outlook, Brain Imaging Modalities Market Opportunity, Brain Imaging Modalities Market Growth, Brain Imaging Modalities Market Share, Brain Imaging Modalities Market Size, Brain Imaging Modalities Market by Application, Brain Imaging Modalities Market by Product, Brain Imaging Modalities Market by Region, Brain Imaging Modalities Market by Patient Type, Brain Imaging Modalities Market by End User, Brain Imaging Modalities Market by Vendor, Adults Brain Imaging Modalities Market, Pediatrics and Infants Brain Imaging Modalities Market, Hospitals and Clinics Brain Imaging Modalities Market, Diagnostic Imaging Centers Brain Imaging Modalities Market, Ambulatory Surgical Centers Brain Imaging Modalities Market, CT Devices Brain Imaging Modalities Market, MRI Devices Brain Imaging Modalities Market, 2D and 3D MRI Ratio Brain Imaging Modalities Market, PET Devices Brain Imaging Modalities Market, PET-CT Devices Brain Imaging Modalities Market, PET-MRI Devices Brain Imaging Modalities Market, North America Brain Imaging Modalities Market, Europe Brain Imaging Modalities Market, Asia-Pacific Brain Imaging Modalities Market
Press Release :
The brain imaging modalities market is projected to reach $20,209.2 million by 2031, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 5.06% during the forecast period 2022-2031.The comprehensive study of the global brain imaging modalities market by BIS Research extensively covers the following:• Market numbers on the indication, patient, product, and end user influencing the market • More than 15 key brain imaging modalities companies offering CT devices, MRI devices, PET devices, PET-MRI devices, and PET-CT devices present in the market • Market share analysis for brain imaging modalities companies• Detailed global and regional market analysis • Region-wise analysis and forecast for various products, patient type, and end users• Competitive product benchmarking analysisTo emphasize the potential of brain imaging modalities, Abdul Wahid, Principal Consultant, BIS Research, states, "The COVID-19 pandemic has had a debilitating impact on the global healthcare ecosystem. Several challenges were faced by hospitals and clinics, including a lack of resources, a high patient influx, and the risk of infection among care providers. Moreover, during the early months of the pandemic, the COVID-19 pandemic had an impact on brain imaging procedures. Nonetheless, the device adoption rate is expected to return to pre-COVID-19 levels during the forecast period. The allocation of funds for purchasing new devices, as well as the speed with which procurement decisions are made, will have a significant impact on device adoption rates."Key Companies Operating in the MarketSome key players operating in the market include Canon Inc., Esaote SpA, FONAR Corporation, Fujifilm Holdings Corporation, General Electric Company, Hyperfine Inc., Koninklijke Philips N.V., MinFound Medical Systems Co., Ltd, Siemens Healthineers AG, Shimadzu Corporation, and Vuno Co., Ltd.How can market intelligence on brain imaging modalities market add value to a business's decision-making process?• Aid in product development • Help in understanding the regulatory scenario of the market in different regions• Aid in understanding the patent trend of the market• Aid in targeting a segment for launching a new product • Aid in understanding the growth potential of different products • Support in analyzing the market opportunities• Provide competitive benchmarking of the key companies in the marketKey Questions Answered in the Report• How has COVID-19 impacted the growth of the global brain imaging modalities market?• What are the key regulations governing the brain imaging modalities market in key regions?• What technological developments are projected to have the maximum influence on the global brain imaging modalities market?• Who are the leading players holding significant dominance in the global brain imaging modalities market?• What are some of the growth opportunities which market players can capitalize on?• What are the drivers and restraints for the global brain imaging modalities market?• Which region has the highest growth rate in the brain imaging modalities market?• Which are the fastest growing countries in terms of the global brain imaging modalities market?• What are the key strategies being adopted by market players in the global brain imaging modalities market?• Which are the emerging companies in the global brain imaging modalities market?
Companies Mentioned :
Aspect ImagingCanon, Inc.Esaote SpAFujifilm Holdings CorporationGeneral Electric CompanyHyperfine Inc.Koninklijke Philips N.V.Mediso Medical Imaging SystemsMinFound Medical Systems Co., Ltd.Samsung Electronics Co., Ltd.Shenzhen Anke High-Tech Co.,Ltd.Shimadzu CorporationSiemens Healthineers AGUnited Imaging Healthcare Co., Ltd.VUNO Co., Ltd.
Press Release :
The brain imaging modalities market is projected to reach $20,209.2 million by 2031, reveals the premium market intelligence study by BIS Research. The study also highlights that the market is set to witness a CAGR of 5.06% during the forecast period 2022-2031.The comprehensive study of the global brain imaging modalities market by BIS Research extensively covers the following:• Market numbers on the indication, patient, product, and end user influencing the market • More than 15 key brain imaging modalities companies offering CT devices, MRI devices, PET devices, PET-MRI devices, and PET-CT devices present in the market • Market share analysis for brain imaging modalities companies• Detailed global and regional market analysis • Region-wise analysis and forecast for various products, patient type, and end users• Competitive product benchmarking analysisTo emphasize the potential of brain imaging modalities, Abdul Wahid, Principal Consultant, BIS Research, states, "The COVID-19 pandemic has had a debilitating impact on the global healthcare ecosystem. Several challenges were faced by hospitals and clinics, including a lack of resources, a high patient influx, and the risk of infection among care providers. Moreover, during the early months of the pandemic, the COVID-19 pandemic had an impact on brain imaging procedures. Nonetheless, the device adoption rate is expected to return to pre-COVID-19 levels during the forecast period. The allocation of funds for purchasing new devices, as well as the speed with which procurement decisions are made, will have a significant impact on device adoption rates."Key Companies Operating in the MarketSome key players operating in the market include Canon Inc., Esaote SpA, FONAR Corporation, Fujifilm Holdings Corporation, General Electric Company, Hyperfine Inc., Koninklijke Philips N.V., MinFound Medical Systems Co., Ltd, Siemens Healthineers AG, Shimadzu Corporation, and Vuno Co., Ltd.How can market intelligence on brain imaging modalities market add value to a business's decision-making process?• Aid in product development • Help in understanding the regulatory scenario of the market in different regions• Aid in understanding the patent trend of the market• Aid in targeting a segment for launching a new product • Aid in understanding the growth potential of different products • Support in analyzing the market opportunities• Provide competitive benchmarking of the key companies in the marketKey Questions Answered in the Report• How has COVID-19 impacted the growth of the global brain imaging modalities market?• What are the key regulations governing the brain imaging modalities market in key regions?• What technological developments are projected to have the maximum influence on the global brain imaging modalities market?• Who are the leading players holding significant dominance in the global brain imaging modalities market?• What are some of the growth opportunities which market players can capitalize on?• What are the drivers and restraints for the global brain imaging modalities market?• Which region has the highest growth rate in the brain imaging modalities market?• Which are the fastest growing countries in terms of the global brain imaging modalities market?• What are the key strategies being adopted by market players in the global brain imaging modalities market?• Which are the emerging companies in the global brain imaging modalities market?
Headline :
Global Brain Imaging Modalities Market to Reach $20,209.2 Million by 2031
Table of Contents :
1 Markets1.1 Market Outlook1.1.1 Product Definition1.1.2 Inclusion and Exclusion Criteria1.1.3 Key Findings1.1.4 Assumptions and Limitations1.1.5 Global Market Scenario1.1.5.1 Realistic Growth Scenario1.1.5.2 Optimistic Growth Scenario1.1.5.3 Pessimistic/Conservative Growth Scenario1.2 Industry Outlook1.2.1 Key Trends1.2.2 Opportunity Assessment1.2.2.1 Short-Term Potential1.2.2.2 Long-Term Potential1.2.3 Patent Analysis1.2.3.1 Awaited Technological Developments1.2.3.2 Patent Publication Growth Trend1.2.3.3 Patent Analysis by Country/Cluster1.2.4 Product Benchmarking1.3 Impact of COVID-191.3.1 Impact on Facilities1.3.2 Impact on Device Adoption1.3.3 Impact on Market Size1.3.3.1 Pre-COVID-19 Phase1.3.3.2 During COVID-19 Phase1.3.3.3 Post-COVID-19 Phase1.4 Business Dynamics1.4.1 Impact Analysis1.4.2 Business Drivers1.4.2.1 Rising Prevalence of Neurological Disorders and Traumatic Brain Injuries (TBI)1.4.2.2 Technological Advancements in the Brain Imaging Modalities and Systems1.4.2.3 Growing Popularity of Molecular Imaging in Brain Imaging1.4.3 Business Restraints1.4.3.1 Hospital Budget Cuts and High Upfront Cost1.4.3.2 Declining Helium Availability1.4.4 Business Opportunities1.4.4.1 Integration of Imaging Systems and Software with Novel Biomarkers2 Application2.1 Global Brain Imaging Modalities Market (by Patient Type)2.1.1 Opportunity Assessment2.1.2 Growth-Share Matrix2.1.3 Adults2.1.3.1 Market Trends2.1.3.2 Market Size and Forecast2.1.4 Pediatrics and Infants2.1.4.1 Market Trends2.1.4.2 Market Size and Forecast2.2 Global Brain Imaging Modalities Market (by End User)2.2.1 Opportunity Assessment2.2.2 Growth-Share Matrix2.2.3 Hospitals and Clinics2.2.4 Diagnostic Imaging Centers2.2.5 Ambulatory Surgical Centers3 Product3.1 Global Brain Imaging Modalities Market (by Product)3.1.1 Opportunity Assessment3.1.2 Market Share Analysis3.1.3 Growth-Share Matrix3.1.3.1 Competitive Benchmarking3.1.4 CT Devices3.1.4.1 Current Market Scenario, Key Findings3.1.4.2 Key Trends3.1.4.3 Production Volume3.1.4.3.1 North America3.1.4.3.2 Europe3.1.4.3.3 Asia-Pacific3.1.4.3.4 Rest-of-the-World3.1.4.4 Market Size and Forecast3.1.4.5 Vendor Analysis3.1.4.5.1 Market Share (by Vendor)3.1.4.5.2 Production Volume (by Vendor)3.1.5 MRI Devices3.1.5.1 Current Market Scenario (Key Findings)3.1.5.2 Key Trends3.1.5.3 Production Volume3.1.5.3.1 North America3.1.5.3.2 Europe3.1.5.3.3 Asia-Pacific3.1.5.3.4 Rest-of-the-World3.1.5.4 Market Size and Forecast3.1.5.5 2D and 3D MRI Ratio3.1.5.5.1 U.S.3.1.5.5.2 EU53.1.5.5.3 Japan3.1.5.5.4 South Korea3.1.5.6 Vendor Analysis3.1.5.6.1 Market Share (by Vendor)3.1.5.6.2 Production Volume (by Vendor)3.1.6 PET Devices3.1.6.1 Current Market Scenario, Key Findings3.1.6.2 Key Trends3.1.6.3 Production Volume3.1.6.3.1 North America3.1.6.3.2 Europe3.1.6.3.3 Asia-Pacific3.1.6.3.4 Rest-of-the-World3.1.6.4 Market Size and Forecast3.1.6.1 Vendor Analysis3.1.6.1.1 Market Share (by Vendor)3.1.6.1.2 Production Volume (by Vendor)3.1.7 PET-CT Devices3.1.7.1 Current Market Scenario, Key Findings3.1.7.2 Key Trends3.1.7.3 Production Volume3.1.7.3.1 North America3.1.7.3.2 Europe3.1.7.3.3 Asia-Pacific3.1.7.3.4 Rest-of-the-World3.1.7.4 Market Size and Forecast3.1.7.5 Vendor Analysis3.1.7.5.1 Market Share (by Vendor)3.1.7.5.2 Production Volume (by Vendor)3.1.8 PET-MRI Devices3.1.8.1 Current Market Scenario, Key Findings3.1.8.2 Key Trends3.1.8.3 Production Volume3.1.8.3.1 North America3.1.8.3.2 Europe3.1.8.3.3 Asia-Pacific3.1.8.3.4 Rest-of-the-World3.1.8.4 Market Size and Forecast3.1.8.5 Vendor Analysis3.1.8.5.1 Market Share (by Vendor)3.1.8.5.2 Production Volume (by Vendor)4 Region4.1 North America Brain Imaging Modalities Market4.1.1 Regulatory Framework4.1.2 Market4.1.2.1 Key Findings and Opportunity Assessment4.1.2.2 Market Dynamics4.1.2.2.1 Impact Analysis4.1.2.3 Sizing and Forecast Analysis4.1.3 Application4.1.3.1 North America Brain Imaging Modalities Market (by Patient Type)4.1.3.2 North America Brain Imaging Modalities Market (by End User)4.1.4 Product4.1.4.1 North America Brain Imaging Modalities Market (by Product Type)4.1.5 North America Brain Imaging Modalities Market (by Country)4.1.5.1 U.S.4.1.5.2 Canada4.2 Europe Brain Imaging Modalities Market4.2.1 Regulatory Framework4.2.2 Market4.2.2.1 Key Findings and Opportunity Assessment4.2.2.2 Market Dynamics4.2.2.2.1 Impact Analysis4.2.2.3 Sizing and Forecast Analysis4.2.3 Application4.2.3.1 Europe Brain Imaging Modalities Market (by Patient Type)4.2.3.2 Europe Brain Imaging Modalities Market (by End User)4.2.4 Product4.2.4.1 Europe Brain Imaging Modalities Market (by Product)4.2.5 Europe Brain Imaging Modalities Market (by Country)4.2.5.1 Germany4.2.5.2 France4.2.5.3 U.K.4.2.5.4 Italy4.2.5.5 Spain4.2.5.6 Rest-of-Europe4.3 Asia-Pacific Brain Imaging Modalities Market4.3.1 Regulatory Framework4.3.2 Market4.3.2.1 Key Findings and Opportunity Assessment4.3.2.2 Market Dynamics4.3.2.2.1 Impact Analysis4.3.2.1 Sizing and Forecast Analysis4.3.3 Application4.3.3.1 Asia-Pacific Brain Imaging Modalities Market (by Patient Type)4.3.3.2 Asia-Pacific Brain Imaging Modalities Market (by End User)4.3.4 Product4.3.4.1 Asia-Pacific Brain Imaging Modalities Market (by Product Type)4.3.5 Asia-Pacific Brain Imaging Modalities Market (by Country)4.3.5.1 China4.3.5.2 Japan4.3.5.3 India4.3.5.4 South Korea4.3.5.5 Australia and New Zealand4.3.5.6 Rest-of-Asia-Pacific4.4 Rest-of-the-World Brain Imaging Modalities Market4.4.1 Regulatory Framework4.4.2 Market4.4.2.1 Key Findings and Opportunity Assessment4.4.2.2 Market Dynamics4.4.2.2.1 Impact Analysis4.4.2.3 Sizing and Forecast Analysis4.4.3 Application4.4.3.1 Rest-of-the-World Brain Imaging Modalities Market (by Patient Type)4.4.3.2 Rest-of-the-World Brain Imaging Modalities Market (by End User)4.4.4 Product4.4.4.1 Rest-of-the-World Brain Imaging Modalities Market (by Product Type)4.4.5 Rest-of-the-World Brain Imaging Modalities Market (by Country)4.4.5.1 Latin America4.4.5.2 Middle East and Africa5 Market- Company Profiles and Competitive Benchmarking5.1 Competitive Landscape5.1.1 Key Strategies and Developments5.1.1.1 Regulatory and Legal Activities5.1.1.2 New Product Offerings and Upgradations5.1.1.3 Partnerships, Alliances, and Business Expansion5.1.1.4 Funding Activities5.1.1.5 Mergers and Acquisitions5.2 Market Share Analysis5.3 Company Profiles5.3.1 Aspect Imaging5.3.1.1 Company Overview5.3.1.2 Role of Aspect Imaging in the Global Brain Imaging Modalities Market5.3.1.3 Product Portfolio and Offerings5.3.1.4 Aspect Imaging: SWOT Analysis5.3.2 Canon, Inc.5.3.2.1 Company Overview5.3.2.2 Role of Canon, Inc. in the Global Brain Imaging Modalities Market5.3.2.3 Product Portfolio and Offerings5.3.2.4 Recent Developments5.3.2.5 Financials5.3.2.6 Canon, Inc.: SWOT Analysis5.3.3 Esaote SpA5.3.3.1 Company Overview5.3.3.2 Role of Esaote SpA in the Global Brain Imaging Modalities Market5.3.3.3 Product Portfolio and Offerings5.3.3.4 Esaote SpA: SWOT Analysis5.3.4 Fujifilm Holdings Corporation5.3.4.1 Company Overview5.3.4.2 Role of Fujifilm Holdings Corporation in the Global Brain Imaging Modalities Market5.3.4.3 Product Portfolio and Offerings5.3.4.4 Financials5.3.4.5 Recent Developments5.3.4.6 Fujifilm Holdings Corporation: SWOT Analysis5.3.5 General Electric Company5.3.5.1 Company Overview5.3.5.2 Role of General Electric Company in the Global Brain Imaging Modalities Market5.3.5.3 Product Portfolio and Offerings5.3.5.4 Financials5.3.5.5 General Electric Company: SWOT Analysis5.3.6 Hyperfine Inc.5.3.6.1 Company Overview5.3.6.2 Role of Hyperfine Inc. in the Global Brain Imaging Modalities Market5.3.6.3 Product Portfolio and Offerings5.3.6.4 Recent Developments5.3.6.5 Hyperfine Inc.: SWOT Analysis5.3.7 Koninklijke Philips N.V.5.3.7.1 Company Overview5.3.7.2 Role of Koninklijke Philips N.V. in the Global Brain Imaging Modalities Market5.3.7.3 Product Portfolio and Offerings5.3.7.4 Financials5.3.7.5 Koninklijke Philips N.V.: SWOT Analysis5.3.8 Mediso Medical Imaging Systems5.3.8.1 Company Overview5.3.8.2 Role of Mediso Medical Imaging Systems in the Global Brain Imaging Modalities Market5.3.8.3 Product Portfolio and Offerings5.3.8.4 Mediso Medical Imaging Systems: SWOT Analysis5.3.9 MinFound Medical Systems Co., Ltd.5.3.9.1 Company Overview5.3.9.2 Role of MinFound Medical Systems Co., Ltd. in the Global Brain Imaging Modalities Market5.3.9.3 Product Portfolio and Offerings5.3.9.4 MinFound Medical Systems Co., Ltd.: SWOT Analysis5.3.10 Samsung Electronics Co., Ltd.5.3.10.1 Company Overview5.3.10.2 Role of Samsung Electronics Co., Ltd. in the Global Brain Imaging Modalities Market5.3.10.3 Product Portfolio and Offerings5.3.10.4 Financials5.3.10.5 Samsung Electronics Co., Ltd.: SWOT Analysis5.3.11 Shenzhen Anke High-Tech Co.,Ltd.5.3.11.1 Company Overview5.3.11.2 Role of Shenzhen Anke High-Tech Co., Ltd. in the Global Brain Imaging Modalities Market5.3.11.3 Product Portfolio and Offerings5.3.11.4 Shenzhen Anke High-Tech Co., Ltd.: SWOT Analysis5.3.12 Shimadzu Corporation5.3.12.1 Company Overview5.3.12.2 Role of Shimadzu Corporation in the Global Brain Imaging Modalities Market5.3.12.3 Product Portfolio and Offerings5.3.12.4 Financials5.3.12.5 Recent Developments5.3.12.6 Shimadzu Corporation: SWOT Analysis5.3.13 Siemens Healthineers AG5.3.13.1 Company Overview5.3.13.2 Role of Siemens Healthineers AG in the Global Brain Imaging Modalities Market5.3.13.3 Product Portfolio and Offerings5.3.13.4 Financials5.3.13.5 Recent Developments5.3.13.6 Siemens Healthineers AG: SWOT Analysis5.3.14 United Imaging Healthcare Co., Ltd.5.3.14.1 Company Overview5.3.14.2 Role of United Imaging Healthcare Co., Ltd. in the Global Brain Imaging Modalities Market5.3.14.3 Product Portfolio and Offerings5.3.14.4 Recent Developments5.3.14.5 United Imaging Healthcare Co., Ltd.: SWOT Analysis5.3.15 VUNO Co., Ltd.5.3.15.1 Company Overview5.3.15.2 Role of VUNO Co., Ltd. in the Global Brain Imaging Modalities Market5.3.15.3 Product Portfolio and Offerings5.3.15.4 Recent Developments5.3.15.5 VUNO Co., Ltd.: SWOT Analysis6 Research Methodology6.1 Data Collection and Analysis6.2 Data Sources6.2.1 Primary Data Sources6.2.2 Secondary Data Sources6.3 Data Triangulation6.4 Market Estimation6.5 Forecast Period Selection Criteria6.6 Assumptions and LimitationsList of Figures Figure 1: Global Brain Imaging Modalities Market, Impact AnalysisFigure 2: Global Brain Imaging Modalities Market Potential, $Million, 2020, 2024, 2027, and 2031Figure 3: Global Brain Imaging Modalities Market (by Product Type)Figure 4: Global Brain Imaging Modalities Market (by End User)Figure 5: Key Developments and Strategies, January 2017-December 2021Figure 6: Global Brain Imaging Modalities Market Growth-Share Matrix, 2021-2031Figure 7: Global Brain Imaging Modalities CoverageFigure 8: Global Brain Imaging Modalities Market, Realistic Growth Scenario, $Million, 2020-2031Figure 9: Global Brain Imaging Modalities Market, Optimistic Growth Scenario, $Million, 2020-2031Figure 10: Global Brain Imaging Modalities Market, Pessimistic Growth Scenario, $Million, 2020-2031Figure 11: Global Brain Imaging Modalities Market, Short-Term Potential, $Million, 2022-2025Figure 12: Global Brain Imaging Modalities Market, Long-Term Growth, $Million, 2026-2031Figure 13: Global Brain Imaging Modalities Market, Patent Publication Growth Trend, January 2018-December 2021Figure 14: Global Brain Imaging Modalities Market, Patent Filing Trend (by Country/Cluster), January 2018-December 2021Figure 15: Pre-COVID-19 Scenario, Global Brain Imaging Modalities MarketFigure 16: Global Brain Imaging Modalities Market, Impact AnalysisFigure 17: Technological Advancements in Brain ImagingFigure 18: Molecular Imaging Techniques: General CharacteristicsFigure 19: Global Brain Imaging Modalities Market (by Patient Type)Figure 20: Global Brain Imaging Modalities Market Incremental Opportunity (by Patient Type), $Million, 2022-2031Figure 21: Global Brain Imaging Modalities Market, Growth-Share Matrix (by Patient Type), 2020-2031Figure 22: Global Brain Imaging Modalities Market (by Adults), $Million, 2020-2031Figure 23: Global Brain Imaging Modalities Market (by Pediatrics and Infants), $Million, 2020-2031Figure 24: Global Brain Imaging Modalities Market (by End User)Figure 25: Global Brain Imaging Modalities Market Incremental Opportunity (by End User), $Million, 2022-2031Figure 26: Global Brain Imaging Modalities Market, Growth-Share Matrix (by End User), 2020-2031Figure 27: Global Brain Imaging Modalities Market (by Hospitals and Clinics), $Million, 2020-2031Figure 28: Global Brain Imaging Modalities Market (by Diagnostic Imaging Centers), $Million, 2020-2031Figure 29: Global Brain Imaging Modalities Market (by Ambulatory Surgical Centers), $Million, 2020-2031Figure 30: Global Brain Imaging Modalities Market (by Product Type)Figure 31: Global Brain Imaging Modalities Market Incremental Opportunity (by Product Type), $Million, 2022-2031Figure 32: Market Share by Product Type, 2021Figure 33: Global Brain Imaging Modalities Market, Growth-Share Matrix (by Product Type), 2020-2031Figure 34: Global Brain Imaging Market Competitive Benchmarking (by Key Players)Figure 35: Global Brain Imaging Modalities Incremental Opportunity Analysis (CT Devices), 2022-2031Figure 36: CT Devices, Key TrendsFigure 37: Global Brain Imaging Modalities Market (by CT Devices), $Million, 2020-2031Figure 38: CT Devices, Market Share (by Vendor), 2021Figure 39: Global Brain Imaging Modalities Incremental Opportunity Analysis (CT Devices), 2022-2031Figure 40: MRI Devices, Key TrendsFigure 41: Global Brain Imaging Modalities Market (by MRI Devices), $Million, 2020-2031Figure 42: 2D and 3D MRI RatioFigure 43: MRI Devices, Market Share (by Vendor), 2021Figure 44: Global Brain Imaging Modalities Incremental Opportunity Analysis (PET Devices), 2022-2031Figure 45: PET Devices, Key TrendsFigure 46: Global Brain Imaging Modalities Market (by PET Devices), $Million, 2020-2031Figure 47: PET Devices, Market Share Analysis (by Vendor), 2021Figure 48: Global Brain Imaging Modalities Incremental Opportunity Analysis (PET-CT Devices), 2022-2031Figure 49: PET-CT Devices, Key TrendsFigure 50: Global Brain Imaging Modalities Market (by PET-CT Devices), $Million, 2020-2031Figure 51: PET-CT Devices, Market Share (by Vendor), 2021Figure 52: Global Brain Imaging Modalities Incremental Opportunity Analysis (PET-MRI Devices), 2022-2031Figure 53: PET-MRI Devices, Key TrendsFigure 54: Global Brain Imaging Modalities Market (PET-MRI Devices), $Million, 2020-2031Figure 55: PET-MRI Devices, Market Share Analysis (by Vendor), 2021Figure 56: Global Brain Imaging Modalities Market (by Region), 2021 and 2031Figure 57: North America Brain Imaging Modalities Market Incremental Growth Opportunity (by Country), $Million, 2022-2031Figure 58: North America Brain Imaging Modalities Market, $Million, 2020-2031Figure 59: North America Brain Imaging Modalities Market (by Patient Type), $Million, 2020-2031Figure 60: North America Brain Imaging Modalities Market (by End User), $Million, 2020-2031Figure 61: North America Brain Imaging Modalities Market (by Product Type), $Million, 2020-2031Figure 62: U.S. Brain Imaging Modalities Market, $Million, 2020-2031Figure 63: Canada Brain Imaging Modalities Market, $Million, 2020-2031Figure 64: Europe Brain Imaging Modalities Market Incremental Growth Opportunity, $Million, 2022-2031Figure 65: Europe Brain Imaging Modalities Market, $Million, 2020-2031Figure 66: Europe Brain Imaging Modalities Market (by Patient Type), $Million, 2020-2031Figure 67: Europe Brain Imaging Modalities Market (by End User), $Million, 2020-2031Figure 68: Europe Brain Imaging Modalities Market (by Product), $Million, 2020-2031Figure 69: Germany Brain Imaging Modalities Market, $Million, 2020-2031Figure 70: France Brain Imaging Modalities Market, $Million, 2020-2031Figure 71: U.K. Brain Imaging Modalities Market, $Million, 2020-2031Figure 72: Italy Brain Imaging Modalities Market, $Million, 2020-2031Figure 73: Spain Brain Imaging Modalities Market, $Million, 2020-2031Figure 74: Rest-of-Europe Brain Imaging Modalities Market, $Million, 2020-2031Figure 75: Asia-Pacific Brain Imaging Modalities Market Incremental Growth Opportunity, $Million, 2022-2031Figure 76: Asia-Pacific Brain Imaging Modalities Market, $Million, 2020-2031Figure 77: Asia-Pacific Brain Imaging Modalities Market (by Patient Type), $Million, 2020-2031Figure 78: Asia-Pacific Brain Imaging Modalities Market (by End User), $Million, 2020-2031Figure 79: Asia-Pacific Brain Imaging Modalities Market (by Product Type), $Million, 2020-2031Figure 80: China Brain Imaging Modalities Market, $Million, 2020-2031Figure 81: Japan Brain Imaging Modalities Market, $Million, 2020-2031Figure 82: India Brain Imaging Modalities Market, $Million, 2020-2031Figure 83: South Korea Brain Imaging Modalities Market, $Million, 2020-2031Figure 84: Australia and New Zealand Brain Imaging Modalities Market, $Million, 2020-2031Figure 85: Rest-of-Asia-Pacific Brain Imaging Modalities Market, $Million, 2020-2031Figure 86: Rest-of-the-World Brain Imaging Modalities Market Incremental Growth Opportunity, $Million, 2022-2031Figure 87: Rest-of-the-World Brain Imaging Modalities Market, $Million, 2020-2031Figure 88: Rest-of-the-World Brain Imaging Modalities Market (by Patient Type), $Million, 2020-2031Figure 89: Rest-of-the-World Brain Imaging Modalities Market (by End User), $Million, 2020-2031Figure 90: Rest-of-the-World Brain Imaging Modalities Market (by Product Type), $Million, 2020-2031Figure 91: Latin America Brain Imaging Modalities Market, $Million, 2020-2031Figure 92: Middle East and Africa Brain Imaging Modalities Market, $Million, 2020-2031Figure 93: Share of Key Developments and Strategies, January 2017-December 2021Figure 94: Regulatory and Legal Activities Share (by Company), January 2017-December 2021Figure 95: New Product Offerings and Upgradations Share (by Company), January 2017-December 2021Figure 96: Partnerships, Alliances, and Business Expansion Share (by Company), January 2017-December 2021Figure 97: Mergers and Acquisitions Share (by Company), January 2017-December 2021Figure 98: Market Share Analysis (by Company), 2021Figure 99: Aspect Imaging: Product OfferingsFigure 100: Canon, Inc.: Product OfferingsFigure 101: Canon, Inc.: Overall Financials, $Million, 2018-2020Figure 102: Canon, Inc.: Net Revenue (by Segment), $Million, 2018-2020Figure 103: Canon, Inc.: Revenue (by Region), $Million, 2018-2020Figure 104: Canon, Inc.: R&D Expenditure, $Million, 2018-2020Figure 105: Esaote SpA: Product OfferingsFigure 106: Fujifilm Holdings Corporation: Product OfferingsFigure 107: Fujifilm Holdings Corporation: Overall Financials, $Million, 2018-2020Figure 108: Fujifilm Holdings Corporation: Net Revenue (by Segment), $Million, 2018-2020Figure 109: Fujifilm Holdings Corporation: Net Revenue (by Region), $Million, 2018-2020Figure 110: Fujifilm Holdings Corporation: R&D Expenditure, $Million, 2018-2020Figure 111: General Electric Company: Product OfferingsFigure 112: General Electric Company.: Overall Financials, $Million, 2018-2020Figure 113: General Electric Company: Net Revenue (by Segment), $Million, 2018-2020Figure 114: General Electric Company: Net Revenue (by Region), $Million, 2018-2020Figure 115: General Electric Company: R&D Expenditure, $Million, 2018-2020Figure 116: Hyperfine Inc.: Product OfferingsFigure 117: Koninklijke Philips N.V.: Product OfferingsFigure 118: Koninklijke Philips N.V.: Overall Financials, $Million, 2018-2020Figure 119: Koninklijke Philips N.V.: Net Revenue (by Segment), $Million, 2018-2020Figure 120: Koninklijke Philips N.V.: Net Revenue (by Region), $Million, 2018-2020Figure 121: Koninklijke Philips N.V.: R&D Expenditure, $Million, 2018-2020Figure 122: Mediso Medical Imaging Systems: Product OfferingsFigure 123: MinFound Medical Systems Co., Ltd.: Product OfferingsFigure 124: Samsung Electronics Co., Ltd.: Product OfferingsFigure 125: Samsung Electronics Co., Ltd.: Overall Financials, $Million, 2018-2020Figure 126: Samsung Electronics Co., Ltd.: Net Revenue (by Segment), $Million, 2018-2020Figure 127: Samsung Electronics Co., Ltd.: Net Revenue (by Region), $Million, 2018-2020Figure 128: Samsung Electronics Co., Ltd.: R&D Expenditure, $Million, 2018-2020Figure 129: Shenzhen Anke High-Tech Co., Ltd.: Product OfferingsFigure 130: Shimadzu Corporation: Product OfferingsFigure 131: Shimadzu Corporation: Overall Financials, $Million, 2018-2020Figure 132: Shimadzu Corporation: Net Revenue (by Segment), $Million, 2018-2020Figure 133: Shimadzu Corporation: Net Revenue (by Region), $Million, 2018-2020Figure 134: Shimadzu Corporation: R&D Expenditure, $Million, 2018-2020Figure 135: Siemens Healthineers AG: Product OfferingsFigure 136: Siemens Healthineers AG: Overall Financials, $Million, 2019-2021Figure 137: Siemens Healthineers AG: Net Revenue (by Segment), $Million, 2019-2021Figure 138: Siemens Healthineers AG: Net Revenue (by Region), $Million, 2019-2021Figure 139: Siemens Healthineers AG: R&D Expenditure, $Million, 2019-2021Figure 140: United Imaging Healthcare Co., Ltd.: Product OfferingsFigure 141: VUNO Co., Ltd.: Product OfferingsFigure 142: Global Brain Imaging Modalities Market: Research MethodologyFigure 143: Primary ResearchFigure 144: Secondary ResearchFigure 145: Data TriangulationFigure 146: Global Brain Imaging Modalities Market Research ProcessFigure 147: Assumptions and LimitationsList of Tables Table 1: Challenges in the Global Brain Imaging Modalities MarketTable 2: Global Brain Imaging Modalities Market, Key TrendsTable 3: Global Brain Imaging Modalities Market, Awaited Technology DevelopmentsTable 4: Global Brain Imaging Modalities Market, Product BenchmarkingTable 5: Global Brain Imaging Modalities Market, Key Trends (by Adults)Table 6: Global Brain Imaging Modalities Market, Key Trends (by Pediatrics and Infants)Table 7: CT Devices, Production Volume (by Region)Table 8: CT Devices, Production Volume (by Vendor)Table 9: MRI Devices, Production Volume (by Region)Table 10: MRI Devices, Production Volume (by Vendor)Table 11: PET Devices, Production Volume (by Region)Table 12: PET Devices, Production Volume (by Vendor)Table 13: PET-CT Devices, Production Volume (by Region)Table 14: PET-CT Devices, Production Volume (by Vendor)Table 15: PET-MRI Devices, Production Volume (by Region)Table 16: PET-MRI Devices, Production Volume (by Vendor)Table 17: North America Brain Imaging Modalities Market, Regulatory FrameworkTable 18: North America Brain Imaging Modalities Market, Impact AnalysisTable 19: Europe Brain Imaging Modalities Market RegulationsTable 20: Challenges in MDR ImplementationTable 21: Europe Brain Imaging Modalities, Impact AnalysisTable 22: Asia-Pacific Brain Imaging Modalities Market RegulationsTable 23: Asia-Pacific Brain Imaging Modalities Market, Impact AnalysisTable 24: Rest-of-the-World Brain Imaging Modalities Market Regulatory FrameworkTable 25: Rest-of-the-World Brain Imaging Modalities Market, Impact AnalysisTable 26: Funding Activities, January 2017-December 2021Table 27: Secondary Data Sources

Additional Info

Author BIS Research INC.
Published by BISRESEARCH
Document type Report
Number of pages 216
Keyword Global Brain Imaging Modalities Market